These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39053286)

  • 21. Treatment of advanced carcinoma of the head and neck with a combination of high-dose infusions of methotrexate (NSC-740) and radiotherapy: a preliminary report on eleven cases.
    Hardingham M; Hulbert MH; Walsh-Waring GP
    Cancer Chemother Rep; 1972 Dec; 56(6):745-50. PubMed ID: 4540844
    [No Abstract]   [Full Text] [Related]  

  • 22. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
    Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.
    Alhazzazi TY; Kamarajan P; Xu Y; Ai T; Chen L; Verdin E; Kapila YL
    Anticancer Res; 2016 Jan; 36(1):49-60. PubMed ID: 26722027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
    Matsumoto F; Ohba S; Fujimaki M; Ikeda K
    Auris Nasus Larynx; 2016 Aug; 43(4):440-5. PubMed ID: 26739949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen.
    Elias EG; Chretien PB; Monnard E; Khan T; Bouchelle WH; Wiernik PH; Lipson SD; Hande KR; Zentai T
    Cancer; 1979 Mar; 43(3):1025-31. PubMed ID: 85477
    [No Abstract]   [Full Text] [Related]  

  • 26. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
    Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
    Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative radiotherapy with simultaneous chemotherapy in high-risk squamous cell carcinoma of the head and neck: a novel standard that opens new questions.
    Giralt J; Bernier J
    Clin Transl Oncol; 2005 Jun; 7(5):181-2. PubMed ID: 15960928
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of the treatment of inoperable recurrences of larynx carcinoma after total laryngectomy].
    Sas-Korczyńska B; Korzeniowski S; Skołyszewski J
    Otolaryngol Pol; 1993; 47(5):420-6. PubMed ID: 7505055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Three cases of head and neck cancer made resectable by hyperthermo-chemo-radiotherapy].
    Fujimura T; Yonemura Y; Kamata T; Takegawa S; Sugiyama K; Nishimura G; Miyata R; Yamaguchi A; Miyazaki I; Nakajima K
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1322-7. PubMed ID: 3430022
    [No Abstract]   [Full Text] [Related]  

  • 30. Multimodal treatment for head and neck cancer.
    Lango MN
    Surg Clin North Am; 2009 Feb; 89(1):43-52, viii. PubMed ID: 19186230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early glottic carcinoma treated by radiotherapy: defining a population for surgical salvage.
    Smee RI; Williams JR; Broadley K; Bridger GP
    Laryngoscope; 2013 Jan; 123(1):171-6. PubMed ID: 23007323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of current and emerging approaches in the field of larynx preservation.
    Denaro N; Russi EG; Lefebvre JL; Merlano MC
    Radiother Oncol; 2014 Jan; 110(1):16-24. PubMed ID: 24139733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer.
    Ohguri T; Imada H; Nakano K; Yahara K; Udaka T; Suzuki H; Korogi Y
    Head Neck; 2008 Aug; 30(8):1027-34. PubMed ID: 18302271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck.
    Biete Solà A; Marruecos Querol J; Calvo Manuel FA; Verger Fransoy E; Rovirosa Casino A; Grau de Castro JJ; de Las Heras González M; Ramos Aguerri A; Palacios Eito A; Veiras Candal C; Solano López MV
    Clin Transl Oncol; 2007 Apr; 9(4):244-50. PubMed ID: 17462977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The latest prospects of investigational drugs for head and neck cancer.
    Elicin O; Ozsahin M
    Expert Opin Investig Drugs; 2017 Mar; 26(3):265-268. PubMed ID: 28056562
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of squamous cell carcinoma of the head and neck with methotrexate and irradiation.
    Friedman M; Daly JF
    Am J Roentgenol Radium Ther Nucl Med; 1967 Feb; 99(2):289-301. PubMed ID: 6020797
    [No Abstract]   [Full Text] [Related]  

  • 37. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
    Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer.
    Wheeler RH; Spencer S; Buchsbaum D; Robert F
    Curr Opin Oncol; 1999 May; 11(3):187-90. PubMed ID: 10328593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
    Saito Y; Hayashi R; Iida Y; Mizumachi T; Fujii T; Matsumoto F; Beppu T; Yoshida M; Shinomiya H; Kamiyama R; Kitano M; Yokoshima K; Fujimoto Y; Hama T; Yamashita T; Okami K; Miura K; Fujisawa T; Sano D; Kato H; Minami S; Sugasawa M; Masuda M; Ota I; Iwae S; Kawata R; Monden N; Imai T; Asakage T; Okada M; Yoshikawa T; Tanioka K; Kitayama M; Doi M; Fujii S; Fujii M; Oridate N; Nakamizo M; Yoshimoto S; Homma A; Nibu KI; Yane K
    Cancer; 2020 Sep; 126(18):4177-4187. PubMed ID: 32648953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer.
    Gan HK; Bernstein LJ; Brown J; Ringash J; Vakilha M; Wang L; Goldstein D; Kim J; Hope A; O'Sullivan B; Waldron J; Abdul Razak AR; Chen EX; Siu LL
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):126-34. PubMed ID: 20708851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.